Nestlé Skin Health Appoints Dr. Johannes J. Baensch as Chief Scientific Officer
Nestlé Skin Health, global leader focused on enhancing the quality of life by delivering science-based solutions for skin health, today announced the appointment of Johannes Baensch as Chief Scientific Officer. Effective immediately, he will lead the company’s global Research and Development activities, leveraging his experience of leadership in innovation to ensure the successful development of novel skin health solutions.
Humberto Antunes, Chief Executive Officer of Nestlé Skin Health, said “I am delighted to welcome Johannes Baensch as our Chief Scientific Officer. Innovation plays a critical role in everything we do. Scientific research and clinical development has been a keystone of our activity since the very first days of our company. With this appointment, we have strong leadership as we move forward and take up the skin health challenges of tomorrow.”
Nestlé Skin Health leverages five research and development centers across the world, where more than 700 people are entirely dedicated to innovation in dermatology. In 2015, 57 new patent applications were submitted and the company received numerous new approvals for both medical and consumer science-based solutions around the world.
“It is an honor and privilege to join Nestlé Skin Health. It is a rare opportunity to drive the scientific innovation journey of a company which has experienced such growth and transformation over the past years. We will succeed by keeping our focus and embracing a holistic view on skin health to create new options for the future. Our global R&D footprint is a fantastic platform to generate excellent products and state of the art knowledge to fuel Nestlé Skin Health’s sustainable growth” said Johannes Baensch, newly appointed Chief Scientific Officer. “I look forward to working with our experienced international teams, the broad healthcare community and scientific networks. Together we will leverage and expand our innovation pipelines with cutting edge science and technology that meet the patient needs and consumer expectations, while supporting and partnering with healthcare professionals.”
Johannes Baensch studied Food Science and Technology and holds a chemical engineering Doctorate from the University of Munich. He spent over 25 years at Nestlé in a variety of roles in R&D management, operations and strategy around the world. For the last five years, he has been Nestlé’s Global Head of R&D, renamed Global Head of Product and Technology Development.
About Nestlé Skin Health
Nestlé Skin Health’s mission is to enhance quality of life by delivering science-based solutions for the health of skin, hair and nails. As one of the category’s leading companies, Nestlé Skin Health conducts ground-breaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health.
Nestlé Skin Health
Sébastien Cros, +41 21 642 76 94
Head of Corporate Communications
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
MINDOL-HOLDINGS21.9.2018 03:02 | pressemeddelelse
AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS
AFTON-CHEMICAL20.9.2018 22:32 | pressemeddelelse
Afton Chemical’s S$380 Million Phase II Expansion of Its Jurong Island Plant is Now Complete
NY-IFF20.9.2018 22:17 | pressemeddelelse
IFF Announces Pricing of €1,100,000,000 Senior Notes Offering
BENTALL-KENNEDY20.9.2018 22:02 | pressemeddelelse
Bentall Kennedy Ranked 1st in Canada, 2nd Globally in the 2018 Global Real Estate Sustainability Benchmark (GRESB) Rankings
PIERRE-FABRE20.9.2018 19:23 | pressemeddelelse
Pierre Fabre Receives EU Approval for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) in Adult Patients with Advanced BRAF-Mutant Melanoma
CLOTHESOURCE20.9.2018 19:22 | pressemeddelelse
Clothesource Report Shows Retail Sales Aren’t Falling or Moving Online: Management’s Let Itself Get Misguided
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum